
Human iPSC-derived Endothelial Cells
Human iPSC-derived endothelial cells provide a reliable and renewable source for vascular biology research. These cells exhibit robust endothelial identity, form functional vascular networks, and respond to angiogenic and inflammatory signals, making them a powerful platform for disease modeling, drug discovery, and regenerative medicine.
Benefits
- Expression of key endothelial markers (CD31/PECAM1, VE-Cadherin, vWF, eNOS)
- Responsive to shear stress, cytokines, and pro-angiogenic/anti-angiogenic factors
- Suitable for vascular disease modeling (atherosclerosis, angiogenesis, thrombosis), tissue engineering, and compound screening
Product Specifications
Feature |
Detail |
---|---|
Identity Markers |
Sucrase isomaltase (enterocytes), (MUC2 (goblet cells), LGR5 (stem cells), Lyz (Paneth cells) |
Quantities |
≥ 500 organoids/ crypt like structures per vial |
Quality Control |
Markers characterization , mycoplasma testing |
Format |
Cryopreserved |
Donor & Reprogramming |
Healthy/ diseased donor-derived iPSCs; Sendai virus reprogramming |
Supplied with |
Handling guide and instructions for differentiation and culture |
- Identity & purity assessed; QC includes tube formation, nitric oxide production, and viability assays
- Cryopreserved, multiple scale sizes available; shipping & storage under liquid nitrogen vapor phase
Explore Endothelial Cells
Discover our high-purity, iPSC-derived ventricular cardiomyocytes designed for cardiac safety, electrophysiology, and drug discovery research. Check out the product details to see how these cells can accelerate your studies.